Potential cost savings in residential care for Alzheimer's disease patients

被引:29
|
作者
Leon, J [1 ]
Moyer, D [1 ]
机构
[1] Ctr Hlth Affairs, Project Hope, Bethesda, MD 20814 USA
来源
GERONTOLOGIST | 1999年 / 39卷 / 04期
关键词
assisted living; Alzheimer's disease; nursing home care; costs of care;
D O I
10.1093/geront/39.4.440
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Data from a 1996 cross-sectional study examining the costs of care for Alzheimer's Disease patients are used to estimate the potential cost savings that could result by substituting assisted living for nursing home care for AD residents with health profiles that appear to be manageable within assisted living facilities that specialize in dementia care. Results indicate that up to 13.9% of nursing home costs could be saved, making such a service substitution an attractive alternative in the provision of residential care for certain categories of AD patients.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 50 条
  • [1] Alzheimer's disease care: Costs and potential savings
    Leon, J
    Cheng, CK
    Neumann, PJ
    HEALTH AFFAIRS, 1998, 17 (06) : 206 - 216
  • [2] Potential savings in the cost of caring for Alzheimer's disease - Treatment with rivastigmine
    Hauber, AB
    Gnanasakthy, A
    Snyder, EH
    Bala, MV
    Richter, A
    Mauskopf, JA
    PHARMACOECONOMICS, 2000, 17 (04) : 351 - 360
  • [3] Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine
    Linkins, KW
    Lloyd, LR
    Hjelmstad, GO
    Strausbaugh, HJ
    PHARMACOECONOMICS, 2000, 18 (06) : 609 - 610
  • [4] Potential savings in the cost of caring for Alzheimer's disease: Treatment with rivastigmine
    Hauber A.B.
    Gnanasakthy A.
    Snyder E.H.
    Bala M.V.
    Richter A.
    Mauskopf J.A.
    PharmacoEconomics, 2000, 17 (4) : 351 - 360
  • [5] Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine - Reply
    Hauber, AB
    Mauskopf, JA
    Snyder, EH
    PHARMACOECONOMICS, 2000, 18 (06) : 610 - 612
  • [6] POTENTIAL COST SAVINGS FOR SELECTED NON-PHARMACOLOGICAL TREATMENT STRATEGIES FOR PATIENTS WITH ALZHEIMER'S DISEASE IN FINLAND
    ROSENVALL, Ari
    SaeaeKSVUORI, Lauri
    FINNE-SOVERI, Harriet
    LINNOSMAA, Ismo
    MALMIVAARA, Antti
    JOURNAL OF REHABILITATION MEDICINE, 2020, 52 (09)
  • [7] Potential Savings in the Cost of Caring for Alzheimer’s DiseaseTreatment with Rivastigmine
    A. Brett Hauber
    Josephine A. Mauskopf
    Edward H. Snyder
    PharmacoEconomics, 2000, 18 (6) : 609 - 612
  • [8] Potential Savings in the Cost of Caring for Alzheimer’s DiseaseTreatment with Rivastigmine
    Karen W. Linkins
    John R. Lloyd
    Gregory O. Hjelmstad
    Holly J. Strausbaugh
    PharmacoEconomics, 2000, 18 : 609 - 609
  • [9] Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine
    Hauber, AB
    Gnanasakthy, A
    Mauskopf, JA
    CLINICAL THERAPEUTICS, 2000, 22 (04) : 439 - 451
  • [10] Care of Patients with Alzheimer's Disease
    Athanasiadou, Eleni
    Tsaloglidou, Areti
    Koukourikos, Konstantinos
    Papathanasiou, Ioanna, V
    Iliadis, Christos H.
    Frantzana, Aikaterini
    Fradelos, Evangelos
    Kourkouta, Lambrini
    GENEDIS 2020: GENETICS AND NEURODEGENERATIVE DISEASES, 2021, 1339